Stay updated on CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial

Sign up to get notified when there's something new on the CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial page

  1. Check
    today
    Change Detected
    Difference
    0.4%
    Check dated 2025-05-08T14:04:03.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:26:42.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-04-24T01:33:13.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has removed detailed descriptions of a Phase 1b study evaluating the safety and immunogenicity of CMB305 in various cancer types, while retaining some key identifiers and a revision number update.
    Difference
    35%
    Check dated 2025-04-16T20:41:09.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.6%
    Check dated 2025-04-09T14:56:34.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-04-02T00:20:01.000Z thumbnail image

Stay in the know with updates to CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial page.